In 2016, cancer biologist Johanna Joyce of the Memorial Sloan Kettering Cancer Center published a study in Science that ...

The American Brain Tumor Association (ABTA) has named Kelly Sitkin as President and CEO, effective February 1, 2025. Sitkin ...

Detecting tumor infiltration during surgery has been a vital concern for over a century. Despite advances in healthcare, the ...

Company founded by 4BIO Capital and Professor Steve Pollard as a spinout from the University of Edinburgh to commercialise its breakthrough Synthetic Super-Enhancer platform, Odysseus, to enable ...

Company founded by 4BIO Capital and Professor Steve Pollard as a spinout from the University of Edinburgh to commercialise ...

Robert F. Kennedy Jr., a 70-year-old environmental lawyer, has long been in the spotlight for his unorthodox health practices ...

Surgery took 9½ hours and saved his life, but it severed the optic nerve in his brain. So Sincic was faced with the reality ...

Bexion Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing a novel class of biologic therapy to ...

Broadway at the Beach is getting into the holiday spirit.They held their annual tree-lighting celebration and firework show ...

Trogenix has emerged from stealth to advance its pipeline of viral immunotherapies for cancer, starting with a lead candidate ...

In mice, dampening the activity of area postrema neurons diminished cancer-induced muscle and fat loss and increased lifespan ...

No, Izzie Stevens didn’t die in Grey’s Anatomy. Izzie was given a Stage 4 metastatic melanoma diagnosis when it was thought that she would be killed off in the fifth season. After her tumor was ...